Related Experiment Video

Updated: Apr 24, 2026

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.4K

BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues

Nathiya Muthalagu1, Melissa R Junttila2, Katrin E Wiese3

  • 1Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Cell Reports
|September 2, 2014
PubMed

Insights

MYC overexpression drives cancer by promoting cell proliferation. This study reveals that BIM, a key protein, is essential for MYC-induced apoptosis, independent of p19ARF.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • MYC is a frequently overexpressed oncogene in human cancers, driving abnormal cell proliferation.
  • The precise mechanisms by which MYC induces apoptosis, a crucial tumor suppressor pathway, remain debated.
  • Key players like p19ARF, p53, and BH3-only proteins (NOXA, PUMA, BIM) are implicated with conflicting evidence.

Purpose of the Study:

  • To systematically investigate the roles of p19ARF and BIM in MYC-induced apoptosis.
  • To compare these roles across various experimental settings, including in vitro, in vivo, and in combination with doxorubicin treatment.
  • To clarify the specific BH3-only proteins mediating MYC's apoptotic effects.

Main Methods:

  • Utilized a unified experimental system for direct comparison.
  • Evaluated MYC-induced apoptosis in vitro and in vivo.
  • Assessed the impact of MYC deregulation in conjunction with doxorubicin chemotherapy.

Main Results:

  • Demonstrated a consistent and specific requirement for BIM in MYC-induced apoptosis across multiple experimental models.
  • Found that PUMA, a p53-responsive BH3 protein, is not specifically required for MYC-induced apoptosis.
  • Observed no evidence supporting a role for p19ARF in MYC-induced apoptosis within the examined tissues.

Conclusions:

  • BIM is a critical mediator of MYC-induced apoptosis, irrespective of p19ARF or p53-dependent pathways.
  • The findings clarify the molecular mechanisms underlying MYC's oncogenic activity and its regulation by apoptosis.
  • This research provides a foundation for understanding MYC-driven cancers and potential therapeutic strategies targeting apoptosis.

More Related Videos

Examining BCL-2 Family Function with Large Unilamellar Vesicles08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

7.4K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

7.9K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K